Lexaria Bioscience Corp Stock Current Ratio
Lexaria Bioscience Corp fundamentals help investors to digest information that contributes to Lexaria Bioscience's financial success or failures. It also enables traders to predict the movement of Lexaria OTC Stock. The fundamental analysis module provides a way to measure Lexaria Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lexaria Bioscience otc stock.
Lexaria |
Lexaria Bioscience Corp OTC Stock Current Ratio Analysis
Lexaria Bioscience's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Lexaria Bioscience Current Ratio | 8.52 X |
Most of Lexaria Bioscience's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lexaria Bioscience Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, Lexaria Bioscience Corp has a Current Ratio of 8.52 times. This is 328.14% higher than that of the Consumer Defensive sector and 183.06% higher than that of the Packaged Foods industry. The current ratio for all United States stocks is notably lower than that of the firm.
Lexaria Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lexaria Bioscience's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Lexaria Bioscience could also be used in its relative valuation, which is a method of valuing Lexaria Bioscience by comparing valuation metrics of similar companies.Lexaria Bioscience is currently under evaluation in current ratio category among related companies.
Lexaria Fundamentals
| Return On Equity | -164.27 | |||
| Return On Asset | -87.72 | |||
| Current Valuation | 21.27 M | |||
| Shares Outstanding | 89.59 M | |||
| Shares Owned By Insiders | 0.60 % | |||
| Shares Owned By Institutions | 0.11 % | |||
| Price To Earning | (13.00) X | |||
| Price To Book | 8.99 X | |||
| Price To Sales | 48.33 X | |||
| Revenue | 384.54 K | |||
| Gross Profit | 276.93 K | |||
| EBITDA | (3.75 M) | |||
| Net Income | (3.93 M) | |||
| Cash And Equivalents | 1.31 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 156.1 K | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 8.52 X | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (2.66 M) | |||
| Earnings Per Share | (0.05) X | |||
| Beta | 2.12 | |||
| Market Capitalization | 18.58 M | |||
| Total Asset | 331 K | |||
| Retained Earnings | (10.99 M) | |||
| Working Capital | (53 K) | |||
| Current Asset | 279 K | |||
| Current Liabilities | 332 K | |||
| Z Score | -10.1 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Lexaria OTC Stock
If you are still planning to invest in Lexaria Bioscience Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lexaria Bioscience's history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |